Page last updated: 2024-09-05

erlotinib hydrochloride and apatorsen

erlotinib hydrochloride has been researched along with apatorsen in 1 studies

Compound Research Comparison

Studies (erlotinib hydrochloride)	Trials (erlotinib hydrochloride)	Recent Studies (post-2010) (erlotinib hydrochloride)	Studies (apatorsen)	Trials (apatorsen)	Recent Studies (post-2010) (apatorsen)
4,353	786	3,033	8	3	8

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beraldi, E; Fazli, L; Gleave, ME; Ionescu, DN; Kumano, M; Lelj-Garolla, B; Nappi, L; Rocchi, P; Zoubeidi, A	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and apatorsen

Article	Year
Hsp27 Inhibition with OGX-427 Sensitizes Non-Small Cell Lung Cancer Cells to Erlotinib and Chemotherapy. Molecular cancer therapeutics, 2015, Volume: 14, Issue:5 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Erlotinib Hydrochloride; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Lung Neoplasms; Male; Mice; Molecular Chaperones; Oligonucleotides; Xenograft Model Antitumor Assays	2015

Article

Year

Hsp27 Inhibition with OGX-427 Sensitizes Non-Small Cell Lung Cancer Cells to Erlotinib and Chemotherapy.

Molecular cancer therapeutics, 2015, Volume: 14, Issue:5

Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Erlotinib Hydrochloride; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Lung Neoplasms; Male; Mice; Molecular Chaperones; Oligonucleotides; Xenograft Model Antitumor Assays

2015